Skip to main content

Table 5 Association between relevant characteristics and treatment outcome (retrospective participants)

From: Knowledge about tuberculosis, treatment adherence and outcome among ambulatory patients with drug-sensitive tuberculosis in two directly-observed treatment centres in Southwest Nigeria

Variable Successful TB treatment (cured + completed treatment), n (%) Unsuccessful TB treatment (defaulted + failed treatment + died), n (%) Treatment success rate (%)
Age (year)
 18–34 829 (46.3) 200 (42.5) 80.6
 35–54 741 (41.4) 194 (41.2) 79.5
  ≥ 55 221 (21.3) 77 (16.3) 74.2
  χ2 = 5.612; p = 0.060  
Sex
 Male 1028 (57.4) 306 (65.0) 77.1
 Female 763 (42.6) 165 (35.0) 82.2
  χ2 = 8.780; p = 0.003*  
HIV status (n = 2117)
 Positive 300 (17.8) 127 (29.5) 70.3
 Negative 1387 (82.2) 303 (70.5) 82.1
  χ2 = 29.11; p = 0.000*  
DOTs clinic attended
 UCH 640 (35.7) 219 (46.5) 74.5
 GCHJ 1151 (64.3) 252 (53.5) 82.0
  χ2 = 18.215; p = 0.000*  
Year of enrolment
 2013 325 (18.1) 72 (15.3) 81.9
 2014 390 (21.8) 103 (21.9) 79.1
 2015 290 (16.2) 75 (15.9) 79.5
 2016 383 (21.4) 103 (21.9) 78.8
 2017 403 (22.5) 118 (25.1) 77.4
  χ2 = 2.973; p = 0.562  
Overall TB treatment success rate within the 5-year period (1791 ÷ 2262) 79.2
  1. Treatment success rate was calculated as number of successful TB treatment divided by the sum of successful TB treatment plus unsuccessful treatment, multiply by 100. HIVHuman Immunodeficiency Virus, UCH University College Hospital, GCHJ Government Chest Hospital Jericho, DOTs Directly Observed Treatment Short-course, *Significance difference with Chi-square test, Level of statistical significance, p < 0.05, n number